use
peripher
blood
sampl
case
sever
acut
respiratori
syndrom
sar
mycoplasma
pneumonia
infect
healthi
adult
measur
total
number
natur
killer
nk
nk
cell
nk
use
flow
cytometr
analysi
calcul
percentag
nk
cell
total
number
nk
nk
cell
percentag
nk
cell
significantli
lower
patient
sar
pneumonia
infect
p
healthi
subject
p
p
p
respect
patient
sever
sar
mild
sar
p
case
sar
antisar
coronavirusspecif
igg
andor
igm
antibodi
without
antibodi
p
p
p
respect
signific
differ
valu
among
patient
sar
without
antisar
coronaviru
antibodi
patient
pneumonia
infect
healthi
subject
number
nk
cell
express
surfac
nk
cell
chang
patient
sar
correl
diseas
sever
presenc
antisar
coronavirusspecif
antibodi
sar
differ
pneumonia
infect
pathogenesi
involv
nk
cell
monitor
total
number
nk
nk
cell
percentag
nk
cell
might
aid
differenti
sar
pneumonia
infect
materi
method
studi
includ
cohort
patient
sar
admit
hospit
beij
china
area
sever
acut
respiratori
syndrom
sar
infecti
diseas
origin
emerg
china
novemb
subsequ
spread
worldwid
investig
involv
intern
collabor
attempt
determin
specif
caus
convert
best
describ
syndrom
specif
diseas
present
novel
coronaviru
name
sar
coronaviru
gener
accept
singl
probabl
caus
agent
report
number
tcell
subset
decreas
peripher
blood
sampl
patient
sar
natur
killer
nk
cell
central
role
antitumor
immun
kill
viru
infect
cell
function
nk
cell
regul
varieti
receptor
includ
lectinlik
receptor
killer
immunoglobulinlik
receptor
howev
potenti
involv
nk
cell
sar
report
explor
whether
number
nk
cell
amount
immunoglobulinlik
receptor
chang
peripher
blood
patient
sar
well
relationship
sever
diseas
diagnost
valu
monitor
number
nk
cell
examin
number
nk
cell
amount
peripher
blood
cohort
patient
sar
blood
sampl
case
mycoplasma
pneumonia
infect
healthi
adult
volunt
studi
control
sampl
march
april
met
diagnost
criteria
issu
health
ministri
peopl
republ
china
april
group
includ
male
femal
whose
age
rang
year
mean
year
diseas
durat
vari
day
mean
day
patient
sar
classifi
sever
diseas
accord
aforement
criteria
antisar
coronavirusspecif
igg
andor
igm
antibodi
posit
case
neg
control
subject
select
patient
pneumonia
men
women
age
rang
year
mean
year
beij
chaoyang
hospitalaffili
capit
univers
medic
scienc
beij
institut
respiratori
medicin
patient
fever
develop
period
diseas
later
identifi
pneumonia
infect
serum
posit
antim
pneumonia
antibodi
healthi
control
group
includ
volunt
men
women
age
rang
year
mean
year
mix
anticoagul
whole
peripher
blood
isothiocyan
chlorophyl
protein
tricolor
antibodi
becton
dickinson
franklin
lake
nj
trucount
tube
becton
dickinson
incub
mixtur
dark
room
temperatur
minut
ad
fac
lyse
solut
becton
dickinson
mix
gentli
follow
anoth
incub
dark
sampl
acquisit
threshold
adjust
minim
debri
ensur
inclus
popul
interest
gate
set
lymphocyt
popul
acquisit
stop
lymphocyt
popul
count
reach
number
result
given
mean
sd
analysi
varianc
unpair
test
use
evalu
signific
differ
among
group
subject
compar
total
number
nk
cell
nk
cell
percentag
nk
cell
differ
group
shown
valu
patient
sar
significantli
lower
patient
pneumonia
infect
p
valu
healthi
subject
p
p
p
respect
sever
sar
case
valu
significantli
lower
case
mild
sar
p
valu
signific
differ
found
group
mild
sar
pneumonia
infect
patient
mild
sar
fewer
nk
cell
healthi
subject
howev
signific
differ
group
total
number
nk
cell
percentag
nk
cell
number
nk
cell
nk
cell
percentag
nk
cell
patient
sar
antisar
coronavirusspecif
igg
andor
igm
antibodi
significantli
lower
patient
without
antibodi
p
p
p
respect
signific
differ
among
number
nk
cell
nk
cell
increas
patient
sar
first
day
diseas
except
patient
whose
nk
cell
nk
cell
respect
day
much
lower
count
control
group
howev
differ
reach
statist
signific
compar
healthi
control
group
day
diseas
number
nk
cell
nk
cell
decreas
quickli
fluctuat
low
level
rest
observ
period
percentag
nk
cell
remain
low
entir
diseas
cours
without
signific
chang
sever
case
sar
posit
antisar
coronavirusspecif
igg
andor
igm
antibodi
wherea
mild
case
posit
antibodi
differ
statist
signific
p
patient
antisar
coronavirusspecif
igg
andor
igm
antibodi
sever
sar
wherea
patient
neg
antibodi
sever
sar
differ
statist
signific
p
cell
cytotox
regul
multitud
receptor
includ
bind
major
histocompat
complex
class
molecul
target
cell
thought
one
import
regul
effect
activ
cytolyt
cell
report
number
subset
nk
cell
chang
hiv
diseas
causal
connect
found
augment
nk
cell
activ
antivir
efficaci
biolog
respons
modifi
murin
aid
model
thu
nk
cell
seem
involv
pathogenesi
hiv
diseas
might
key
role
resist
retroviru
howev
knowledg
relationship
nk
cell
sar
describ
studi
cohort
reveal
number
nk
cell
significantli
lower
patient
sar
control
subject
addit
amount
express
surfac
nk
cell
membran
percentag
cell
posit
also
decreas
peripher
blood
sampl
patient
sar
similar
chang
detect
patient
hiv
infect
aid
fewer
nk
cell
decreas
percentag
cell
express
nk
receptor
immunoglobulin
superfamili
compar
healthi
control
subject
peptid
hypothes
regul
nk
activ
sar
viru
alter
number
function
nk
cell
need
studi
mechan
downregul
patient
sar
unknown
postul
mechan
might
involv
process
one
detach
surfac
nk
cell
becom
solubl
serum
express
downregul
transcript
translat
level
unclear
fewer
nk
cell
peripher
blood
patient
sar
possibl
sar
viru
directli
attack
nk
cell
caus
death
also
possibl
nk
cell
undergo
cytolysi
kill
target
cell
infect
viru
altern
nk
cell
might
redistribut
target
organ
lung
number
nk
cell
circul
decreas
anoth
potenti
mechan
sar
viru
metabol
product
act
superantigen
stimul
nk
cell
induc
activationinduc
apoptosi
mechan
patient
sar
show
increas
number
nk
cell
first
day
diseas
increas
reach
statist
signific
compar
healthi
control
group
day
diseas
number
nk
cell
nk
cell
stay
low
level
began
recov
day
diseas
pattern
differ
chang
pattern
tcell
subset
decreas
recov
earlier
nk
cell
entir
diseas
cours
percentag
nk
cell
remain
low
level
indic
amount
nk
cell
reduc
sar
infect
whole
period
observ
regardless
recoveri
nk
cell
count
number
nk
cell
nk
cell
percentag
nk
cell
case
sever
sar
significantli
lower
mild
case
tabl
therefor
number
function
nk
cell
correl
sever
sar
conceiv
higher
viru
load
virul
nk
cell
kill
sever
clinic
symptom
data
show
number
nk
cell
nk
cell
percentag
nk
cell
correl
detect
antisar
coronavirusspecif
antibodi
patient
sar
diagnos
clinic
criteria
valu
case
sar
antisar
coronavirusspecif
antibodi
significantli
lower
case
without
antibodi
tabl
signific
differ
among
group
patient
sar
without
antibodi
patient
pneumonia
infect
healthi
subject
number
nk
cell
nk
cell
percentag
nk
cell
previous
shown
patient
clinic
diagnos
sar
without
antisar
coronavirusspecif
antibodi
similar
healthi
volunt
term
express
cell
wherea
patient
sar
antibodi
lower
express
unpublish
observ
addit
patient
antisar
coronavirusspecif
igg
andor
igm
antibodi
sever
diseas
wherea
patient
neg
antibodi
sever
sar
symptom
patient
posit
antisar
coronavirusspecif
antibodi
much
sever
symptom
patient
without
antibodi
therefor
patient
antisar
coronavirusspecif
antibodi
differ
without
antibodi
immunolog
clinic
henc
doubt
patient
clinic
diagnos
sar
antisar
coronavirusspecif
antibodi
realli
infect
sar
coronaviru
therefor
patient
without
antisar
coronavirusspecif
antibodi
separ
patient
antibodi
unlik
sar
case
littl
chang
number
nk
cell
nk
cell
percentag
nk
cell
patient
pneumonia
infect
indic
nk
cell
differ
role
diseas
although
differ
number
nk
cell
nk
cell
percentag
nk
cell
patient
mild
sar
patient
pneumonia
infect
reach
statist
signific
almost
mild
sar
case
neg
antisar
coronavirusspecif
antibodi
cell
count
percentag
antibodyposit
sar
case
might
consid
true
sar
case
significantli
lower
case
pneumonia
infect
clinic
diagnos
antibodyneg
case
sar
might
consid
fals
sar
therefor
monitor
number
percentag
nk
cell
use
differenti
true
sar
fals
sar
pneumonia
infect
